Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/176791
Title: | HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019 |
Author: | Bruni, Laia Saura Lázaro, Anna Montoliu, Alexandra Brotons, Maria Alemany i Vilches, Laia Diallo, Mamadou Saliou Afsar, Oya Zeren Lamontagne, D. Scott Mosina, Liudmila Contreras, Marcela Velandia González, Martha Pastore, Roberta Gacic Dobo, Marta Bloem, Paul |
Keywords: | Càncer de coll uterí Vacuna del papil·lomavirus Cervix cancer Papillomavirus vaccines |
Issue Date: | 1-Mar-2021 |
Publisher: | Elsevier B. V. |
Abstract: | WHO/UNICEF estimates for HPV vaccination coverage from 2010 to 2019 are analyzed against the backdrop of the 90% coverage target for HPV vaccination by 2030 set in the recently approved global strategy for cervical cancer elimination as a public health problem. As of June 2020, 107 (55%) of the 194 WHO Member States have introduced HPV vaccination. The Americas and Europe are by far the WHO regions with the most introductions, 85% and 77% of their countries having already introduced respectively. A record number of introductions was observed in 2019, most of which in low- and middle- income countries (LMIC) where access has been limited. Programs had an average performance coverage of around 67% for the first dose and 53% for the final dose of HPV. LMICs performed on average better than high- income countries for the first dose, but worse for the last dose due to higher dropout. Only 5 (6%) countries achieved coverages with the final dose of more than 90%, 22 countries (21%) achieved coverages of 75% or higher while 35 (40%) had a final dose coverage of 50% or less. When expressed as world population coverage (i.e., weighted by population size), global coverage of the final HPV dose for 2019 is estimated at 15%. There is a long way to go to meet the 2030 elimination target of 90%. In the post-COVID era attention should be paid to maintain the pace of introductions, specially ensuring the most populous countries introduce, and further improving program performance globally. |
Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.ypmed.2020.106399 |
It is part of: | Preventive Medicine, 2021, vol. 144 |
URI: | http://hdl.handle.net/2445/176791 |
Related resource: | https://doi.org/10.1016/j.ypmed.2020.106399 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S0091743520304308-main.pdf | 8.26 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License